Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants

PLoS Medicine
Damon DemingRalph Baric


In 2003, severe acute respiratory syndrome coronavirus (SARS-CoV) was identified as the etiological agent of severe acute respiratory syndrome, a disease characterized by severe pneumonia that sometimes results in death. SARS-CoV is a zoonotic virus that crossed the species barrier, most likely originating from bats or from other species including civets, raccoon dogs, domestic cats, swine, and rodents. A SARS-CoV vaccine should confer long-term protection, especially in vulnerable senescent populations, against both the 2003 epidemic strains and zoonotic strains that may yet emerge from animal reservoirs. We report the comprehensive investigation of SARS vaccine efficacy in young and senescent mice following homologous and heterologous challenge. Using Venezuelan equine encephalitis virus replicon particles (VRP) expressing the 2003 epidemic Urbani SARS-CoV strain spike (S) glycoprotein (VRP-S) or the nucleocapsid (N) protein from the same strain (VRP-N), we demonstrate that VRP-S, but not VRP-N vaccines provide complete short- and long-term protection against homologous strain challenge in young and senescent mice. To test VRP vaccine efficacy against a heterologous SARS-CoV, we used phylogenetic analyses, synthetic biology, ...Continue Reading


Jun 1, 1992·Computer Applications in the Biosciences : CABIOS·D T JonesJ M Thornton
Feb 26, 1998·Immunological Reviews·H SongJ Cerny
Feb 26, 1998·Immunological Reviews·B ZhengG Kelsoe
Feb 2, 2000·The EMBO Journal·E HerreraM A Blasco
Aug 29, 2001·Bioinformatics·J P Huelsenbeck, F Ronquist
Jul 18, 2002·IUBMB Life·Nancy L DavisRobert E Johnston
Apr 12, 2003·The New England Journal of Medicine·Christian DrostenHans Wilhelm Doerr
Apr 12, 2003·The New England Journal of Medicine·Thomas G KsiazekUNKNOWN SARS Working Group
Jun 26, 2003·Nucleic Acids Research·Ramu ChennaJulie D Thompson
Aug 13, 2003·Bioinformatics·Fredrik Ronquist, John P Huelsenbeck
Oct 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Boyd YountRalph S Baric
Dec 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·Hamilton O SmithJ Craig Venter
Jan 31, 2004·Science·UNKNOWN Chinese SARS Molecular Epidemiology Consortium
Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jianhua SuiWayne A Marasco
Apr 15, 2004·Immunology Letters·Min-Sheng ZhuKai-Hua Tao
Apr 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Himani BishtBernard Moss
Jun 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ursula J BuchholzPeter L Collins
Aug 18, 2004·International Immunology·Naomi TakasukaYasuko Tsunetsugu-Yokota
Oct 23, 2004·Emerging Infectious Diseases·I F N HungK Y Yuen
Nov 9, 2004·Biochemical and Biophysical Research Communications·Yuxian HeShibo Jiang
Nov 24, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Chung-Ming ChuKwok-Yung Yuen
Jan 5, 2005·Biochemical and Biophysical Research Communications·Zhijun WangYung-Fu Chang
Jan 12, 2005·Proceedings of the National Academy of Sciences of the United States of America·Zhi-yong YangGary J Nabel
Jan 22, 2005·Annual Review of Medicine·Danuta M SkowronskiLorne Babiuk
Feb 1, 2005·Journal of Virology·L L M PoonJ S M Peiris

❮ Previous
Next ❯


Jul 11, 2007·Proceedings of the National Academy of Sciences of the United States of America·Zhongyu ZhuDimiter S Dimitrov
Jun 17, 2014·Virus Research·Fernando AlmazánLuis Enjuanes
Oct 16, 2007·Clinical Microbiology Reviews·Vincent C C ChengKwok Yung Yuen
Dec 5, 2008·Microbiology and Molecular Biology Reviews : MMBR·Matthew Frieman, Ralph Baric
Dec 17, 2008·PLoS Pathogens·Timothy SheahanMark T Heise
Feb 10, 2009·Nature Reviews. Microbiology·Lanying DuShibo Jiang
May 12, 2009·Nature Reviews. Microbiology·Stanley Perlman, Jason Netland
Jan 28, 2009·Epidemiology and Infection·M T HeiseF J Burt
Nov 10, 2015·Nature Medicine·Vineet D MenacheryRalph S Baric
May 15, 2007·Virus Research·Anjeanette RobertsKanta Subbarao
Apr 10, 2007·Virus Research·Luis EnjuanesRalph Baric
Jul 21, 2015·Antiviral Research·Neeltje van Doremalen, Vincent J Munster
Jul 18, 2015·Current Opinion in Virology·Lisa M Gretebeck, Kanta Subbarao
Mar 7, 2014·Proceedings of the National Academy of Sciences of the United States of America·Jincun ZhaoStanley Perlman
Mar 4, 2014·Pathogens and Disease·Shauna Milne-PriceVincent J Munster
Apr 12, 2016·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Stanley Perlman, Rahul Vijay
Feb 15, 2008·PLoS Medicine·Lisa C LindesmithRalph S Baric
Oct 28, 2016·Reviews in Medical Virology·Naif Khalaf Alharbi
Mar 24, 2017·Scientific Reports·Sawsan S Al-AmriAnwar M Hashem

❮ Previous
Next ❯

Datasets Mentioned


Methods Mentioned

in vitro transcription
enzyme-linked immunosorbent assay

Software Mentioned


Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.